Previous close | 8.57 |
Open | 8.50 |
Bid | 0.00 x 1800 |
Ask | 0.00 x 2200 |
Day's range | 8.35 - 8.64 |
52-week range | 6.30 - 12.67 |
Volume | |
Avg. volume | 1,024,185 |
Market cap | 3.443B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.17 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 20 Apr 2022 |
1y target est | 11.57 |
Braskem S.A. (NYSE:BAK) Q4 2023 Earnings Call Transcript March 19, 2024 Braskem S.A. misses on earnings expectations. Reported EPS is $-0.8 EPS, expectations were $-0.55. BAK isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone, and thank you […]
BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 4Q23 Earnings Release.
HOUSTON & PHILADELPHIA, March 14, 2024--Shell Chemicals recently started to supply Braskem (BM&FBOVESPA: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK) with bio-attributed and bio-circular propylene feedstocks, based on a mass balance approach and independently certified by a third party.